UK Markets closed

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.40-0.24 (-4.26%)
At close: 4:00PM EST
Currency in USD

Valuation measures

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 312.61
52-week low 34.81
50-day moving average 36.38
200-day moving average 37.00

Share statistics

Avg vol (3-month) 32.26M
Avg vol (10-day) 3820.63k
Shares outstanding 572.65M
Implied shares outstanding 6N/A
Float 821.89M
% held by insiders 160.54%
% held by institutions 128.00%
Shares short (29 Sept 2021) 41.2M
Short ratio (29 Sept 2021) 40.24
Short % of float (29 Sept 2021) 43.79%
Short % of shares outstanding (29 Sept 2021) 41.66%
Shares short (prior month 30 Aug 2021) 41.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,592.01%

Management effectiveness

Return on assets (ttm)-19.15%
Return on equity (ttm)-33.76%

Income statement

Revenue (ttm)2.07M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-44.06M
EBITDA -72.49M
Net income avi to common (ttm)-74.3M
Diluted EPS (ttm)-1.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)199.14M
Total cash per share (mrq)2.74
Total debt (mrq)2.7M
Total debt/equity (mrq)1.42
Current ratio (mrq)17.12
Book value per share (mrq)2.87

Cash flow statement

Operating cash flow (ttm)-68.32M
Levered free cash flow (ttm)-42.91M